Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
10,154
archived clinical trials in
Other Indications

Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Wiiliam Beaumont Hospital
mi
from
Royal oak, MI
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Wiiliam Beaumont Hospital
mi
from
Royal oak, MI
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Mayo Clinic Rochester
mi
from
Rochester, MN
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Mayo Clinic Rochester
mi
from
Rochester, MN
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
St Louis University
mi
from
St Louis, MO
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
St Louis University
mi
from
St Louis, MO
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Women's Healthcare Specialists of St. Louis LLC
mi
from
St. Louis, MO
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Women's Healthcare Specialists of St. Louis LLC
mi
from
St. Louis, MO
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
The Methodist Hospital Research Institute
mi
from
Houston, TX
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
The Methodist Hospital Research Institute
mi
from
Houston, TX
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Cooper University Hospital
mi
from
Camden, NJ
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Cooper University Hospital
mi
from
Camden, NJ
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Lyndhurst Gynecologic Associates
mi
from
Winston Salem, NC
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Lyndhurst Gynecologic Associates
mi
from
Winston Salem, NC
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Complete Healthcare for Women
mi
from
Columbus, OH
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Complete Healthcare for Women
mi
from
Columbus, OH
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Clinical Trials of America
mi
from
Eugene, OR
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Clinical Trials of America
mi
from
Eugene, OR
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Thomas Jefferson Hospital
mi
from
Philadelphia, PA
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Thomas Jefferson Hospital
mi
from
Philadelphia, PA
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Medical University of South Carolina
mi
from
Charleston, SC
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Medical University of South Carolina
mi
from
Charleston, SC
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Kingsport Perinatology
mi
from
Kingsport, TN
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Kingsport Perinatology
mi
from
Kingsport, TN
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Brown University, Women & Infants Hospital of Rhode Island
mi
from
Providence, RI
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Brown University, Women & Infants Hospital of Rhode Island
mi
from
Providence, RI
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Perinatal Research Center
mi
from
Nashville, TN
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Perinatal Research Center
mi
from
Nashville, TN
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Tenessee Maternal Fetal Medicine
mi
from
Nashville, TN
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Tenessee Maternal Fetal Medicine
mi
from
Nashville, TN
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Houston Perinatal Associates
mi
from
Houston, TX
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Status: Archived
Updated: 1/1/1970
Houston Perinatal Associates
mi
from
Houston, TX
Comparison Between Pyloric Preserving and Non-Pyloric Preserving Bariatric Surgery With Glucose Challenge
Comparison Between Pyloric Preserving and Non-Pyloric Preserving Bariatric Surgery With Glucose Challenge
Status: Archived
Leo W. Jenkins Cancer Center
mi
from
Greenville, NC
Comparison Between Pyloric Preserving and Non-Pyloric Preserving Bariatric Surgery With Glucose Challenge
Comparison Between Pyloric Preserving and Non-Pyloric Preserving Bariatric Surgery With Glucose Challenge
Status: Archived
Updated: 1/1/1970
Leo W. Jenkins Cancer Center
mi
from
Greenville, NC
The Effect of Weight on Vitamin D Dose Response
The Effect of Weight on Vitamin D Dose Response
Status: Archived
Creighton University
mi
from
Omaha, NE
The Effect of Weight on Vitamin D Dose Response
The Effect of Weight on Vitamin D Dose Response
Status: Archived
Updated: 1/1/1970
Creighton University
mi
from
Omaha, NE
A Pilot Study of Bevacizumab (Avastin) in Patients With Unresectable or Recurrent Hemangioblastoma From Von-Hippel-Lindau Disease
D0904 - A Pilot Study of Bevacizumab (Avastin) in Patients With Unresectable or Recurrent Hemangioblastoma From Von Hippel-Lindau Disease.
Status: Archived
Darien Pediatric Associates
mi
from
Darien, CT
A Pilot Study of Bevacizumab (Avastin) in Patients With Unresectable or Recurrent Hemangioblastoma From Von-Hippel-Lindau Disease
D0904 - A Pilot Study of Bevacizumab (Avastin) in Patients With Unresectable or Recurrent Hemangioblastoma From Von Hippel-Lindau Disease.
Status: Archived
Updated: 1/1/1970
Darien Pediatric Associates
mi
from
Darien, CT
Concurrent Single Gene and 24 Chromosome Aneuploidy Preimplantation Genetic Diagnosis (PGD)
First Use of Parental Support Technology(R) for Single Gene Analysis Plus Aneuploidy Screening in Preimplantation Genetic Diagnosis
Status: Archived
Gene Security Network
mi
from
Redwood City, CA
Concurrent Single Gene and 24 Chromosome Aneuploidy Preimplantation Genetic Diagnosis (PGD)
First Use of Parental Support Technology(R) for Single Gene Analysis Plus Aneuploidy Screening in Preimplantation Genetic Diagnosis
Status: Archived
Updated: 1/1/1970
Gene Security Network
mi
from
Redwood City, CA
A Study of Flurbiprofen 8.75 mg Lozenge in Patients With Pharyngitis
A Repeat-Dose, Multi-Centre, Randomized, Double-Blind, Placebo-Controlled, Study to Determine the Safety and Efficacy of Flurbiprofen 8.75 mg Lozenge Compared to Its Vehicle Control Lozenge in Patients With Painful Pharyngitis
Status: Archived
Bluestone Center for Clinical Research
mi
from
New York, NY
A Study of Flurbiprofen 8.75 mg Lozenge in Patients With Pharyngitis
A Repeat-Dose, Multi-Centre, Randomized, Double-Blind, Placebo-Controlled, Study to Determine the Safety and Efficacy of Flurbiprofen 8.75 mg Lozenge Compared to Its Vehicle Control Lozenge in Patients With Painful Pharyngitis
Status: Archived
Updated: 1/1/1970
Bluestone Center for Clinical Research
mi
from
New York, NY
A Study of Flurbiprofen 8.75 mg Lozenge in Patient With Pharyngitis
A Randomized, Double-Blind, Placebo-Controlled Multiple-Dose Study to Determine the Efficacy, Onset, and Duration of Action of Flurbiprofen 8.75 mg Lozenge Compared to Its Vehicle Control Lozenge in Patients With Painful Pharyngitis
Status: Archived
Bluestone Center for Clinical Research
mi
from
New York, NY
A Study of Flurbiprofen 8.75 mg Lozenge in Patient With Pharyngitis
A Randomized, Double-Blind, Placebo-Controlled Multiple-Dose Study to Determine the Efficacy, Onset, and Duration of Action of Flurbiprofen 8.75 mg Lozenge Compared to Its Vehicle Control Lozenge in Patients With Painful Pharyngitis
Status: Archived
Updated: 1/1/1970
Bluestone Center for Clinical Research
mi
from
New York, NY
Trial of Minocycline to Treat Children With Fragile X Syndrome
Randomized Double-Blind Controlled Cross Over Trial of Minocycline in Children With Fragile X Syndrome
Status: Archived
University of California, San Francisco, Fresno, School of Medicine
mi
from
Fresno, CA
Trial of Minocycline to Treat Children With Fragile X Syndrome
Randomized Double-Blind Controlled Cross Over Trial of Minocycline in Children With Fragile X Syndrome
Status: Archived
Updated: 1/1/1970
University of California, San Francisco, Fresno, School of Medicine
mi
from
Fresno, CA
Evaluate the Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg vs. Placebo
A Double Blind, Randomized, Parallel Controlled Study to Evaluate the Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg vs. Placebo as a Urinary Analgesic for Short Term Treatment in Female Subjects Suffering From Pain or Burning When Passing Urine Associated With Uncomplicated Urinary Tract Infections (uUTI)
Status: Archived
Oxford Pharmaceutical Resources, Inc.
mi
from
Totowa, NJ
Evaluate the Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg vs. Placebo
A Double Blind, Randomized, Parallel Controlled Study to Evaluate the Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg vs. Placebo as a Urinary Analgesic for Short Term Treatment in Female Subjects Suffering From Pain or Burning When Passing Urine Associated With Uncomplicated Urinary Tract Infections (uUTI)
Status: Archived
Updated: 1/1/1970
Oxford Pharmaceutical Resources, Inc.
mi
from
Totowa, NJ
Topical Cyclosporine Suspension for the Treatment of Brittle Nails
A Single Center, Investigator-blinded Study of the Efficacy of Topical Cyclosporine 0.05% Ophthalmic Suspension (RESTASIS®) Under Occlusion Versus Vehicle in the Treatment of Brittle Nail Syndrome
Status: Archived
University of North Carolina Hospital at Chapel Hill
mi
from
Chapel Hill, NC
Topical Cyclosporine Suspension for the Treatment of Brittle Nails
A Single Center, Investigator-blinded Study of the Efficacy of Topical Cyclosporine 0.05% Ophthalmic Suspension (RESTASIS®) Under Occlusion Versus Vehicle in the Treatment of Brittle Nail Syndrome
Status: Archived
Updated: 1/1/1970
University of North Carolina Hospital at Chapel Hill
mi
from
Chapel Hill, NC
Vitamin D Supplementation Reduces Renin-Angiotensin System Activity in Obesity
Vitamin D Deficiency Augments Renin-Angiotensin System Activity in Obesity
Status: Archived
Brigham and Women's Hosp
mi
from
Boston, MA
Vitamin D Supplementation Reduces Renin-Angiotensin System Activity in Obesity
Vitamin D Deficiency Augments Renin-Angiotensin System Activity in Obesity
Status: Archived
Updated: 1/1/1970
Brigham and Women's Hosp
mi
from
Boston, MA
Safety and Efficacy of Moxidex Otic
Status: Archived
Alcon Call Center
mi
from
Fort Worth, TX
Safety and Efficacy of Moxidex Otic
Status: Archived
Updated: 1/1/1970
Alcon Call Center
mi
from
Fort Worth, TX
Utility of a Urine Screening Tool for Vitamin D Deficiency in Infants and Toddlers
Utility of the Urine Calcium Creatinine Ratio as a Screening Tool for Vitamin D Deficiency in Infants and Toddlers
Status: Archived
Nemours Children's Clinic
mi
from
Jacksonville, FL
Utility of a Urine Screening Tool for Vitamin D Deficiency in Infants and Toddlers
Utility of the Urine Calcium Creatinine Ratio as a Screening Tool for Vitamin D Deficiency in Infants and Toddlers
Status: Archived
Updated: 1/1/1970
Nemours Children's Clinic
mi
from
Jacksonville, FL
MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy
A Prospective, Multi-center Observational Study With Blinded, Nested Case:Control Analyses to Evaluate the Performance of the Artemis Health Prenatal Aneuploidy Diagnostic Test
Status: Archived
Center for Fetal Medicine
mi
from
Los Angeles, CA
MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy
A Prospective, Multi-center Observational Study With Blinded, Nested Case:Control Analyses to Evaluate the Performance of the Artemis Health Prenatal Aneuploidy Diagnostic Test
Status: Archived
Updated: 1/1/1970
Center for Fetal Medicine
mi
from
Los Angeles, CA
MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy
A Prospective, Multi-center Observational Study With Blinded, Nested Case:Control Analyses to Evaluate the Performance of the Artemis Health Prenatal Aneuploidy Diagnostic Test
Status: Archived
San Francisco Perinatal Associates
mi
from
San Francisco, CA
MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy
A Prospective, Multi-center Observational Study With Blinded, Nested Case:Control Analyses to Evaluate the Performance of the Artemis Health Prenatal Aneuploidy Diagnostic Test
Status: Archived
Updated: 1/1/1970
San Francisco Perinatal Associates
mi
from
San Francisco, CA
MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy
A Prospective, Multi-center Observational Study With Blinded, Nested Case:Control Analyses to Evaluate the Performance of the Artemis Health Prenatal Aneuploidy Diagnostic Test
Status: Archived
Women's Clinic
mi
from
Boise, ID
MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy
A Prospective, Multi-center Observational Study With Blinded, Nested Case:Control Analyses to Evaluate the Performance of the Artemis Health Prenatal Aneuploidy Diagnostic Test
Status: Archived
Updated: 1/1/1970
Women's Clinic
mi
from
Boise, ID
MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy
A Prospective, Multi-center Observational Study With Blinded, Nested Case:Control Analyses to Evaluate the Performance of the Artemis Health Prenatal Aneuploidy Diagnostic Test
Status: Archived
Visions Clinical Research
mi
from
Boynton Beach, FL
MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy
A Prospective, Multi-center Observational Study With Blinded, Nested Case:Control Analyses to Evaluate the Performance of the Artemis Health Prenatal Aneuploidy Diagnostic Test
Status: Archived
Updated: 1/1/1970
Visions Clinical Research
mi
from
Boynton Beach, FL
MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy
A Prospective, Multi-center Observational Study With Blinded, Nested Case:Control Analyses to Evaluate the Performance of the Artemis Health Prenatal Aneuploidy Diagnostic Test
Status: Archived
Women's Medical Research Group, LLC
mi
from
Clearwater, FL
MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy
A Prospective, Multi-center Observational Study With Blinded, Nested Case:Control Analyses to Evaluate the Performance of the Artemis Health Prenatal Aneuploidy Diagnostic Test
Status: Archived
Updated: 1/1/1970
Women's Medical Research Group, LLC
mi
from
Clearwater, FL
MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy
A Prospective, Multi-center Observational Study With Blinded, Nested Case:Control Analyses to Evaluate the Performance of the Artemis Health Prenatal Aneuploidy Diagnostic Test
Status: Archived
Comprehensive Clinical Trials
mi
from
West Palm Beach, FL
MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy
A Prospective, Multi-center Observational Study With Blinded, Nested Case:Control Analyses to Evaluate the Performance of the Artemis Health Prenatal Aneuploidy Diagnostic Test
Status: Archived
Updated: 1/1/1970
Comprehensive Clinical Trials
mi
from
West Palm Beach, FL
MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy
A Prospective, Multi-center Observational Study With Blinded, Nested Case:Control Analyses to Evaluate the Performance of the Artemis Health Prenatal Aneuploidy Diagnostic Test
Status: Archived
OB/Gyn Specialists of the Palm Beaches
mi
from
West Palm Beach, FL
MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy
A Prospective, Multi-center Observational Study With Blinded, Nested Case:Control Analyses to Evaluate the Performance of the Artemis Health Prenatal Aneuploidy Diagnostic Test
Status: Archived
Updated: 1/1/1970
OB/Gyn Specialists of the Palm Beaches
mi
from
West Palm Beach, FL
MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy
A Prospective, Multi-center Observational Study With Blinded, Nested Case:Control Analyses to Evaluate the Performance of the Artemis Health Prenatal Aneuploidy Diagnostic Test
Status: Archived
New Mexico Consortium for Perinatal Research
mi
from
Albuquerque, NM
MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy
A Prospective, Multi-center Observational Study With Blinded, Nested Case:Control Analyses to Evaluate the Performance of the Artemis Health Prenatal Aneuploidy Diagnostic Test
Status: Archived
Updated: 1/1/1970
New Mexico Consortium for Perinatal Research
mi
from
Albuquerque, NM
MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy
A Prospective, Multi-center Observational Study With Blinded, Nested Case:Control Analyses to Evaluate the Performance of the Artemis Health Prenatal Aneuploidy Diagnostic Test
Status: Archived
Winthrop University Hospital
mi
from
Mineola, NY
MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy
A Prospective, Multi-center Observational Study With Blinded, Nested Case:Control Analyses to Evaluate the Performance of the Artemis Health Prenatal Aneuploidy Diagnostic Test
Status: Archived
Updated: 1/1/1970
Winthrop University Hospital
mi
from
Mineola, NY
MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy
A Prospective, Multi-center Observational Study With Blinded, Nested Case:Control Analyses to Evaluate the Performance of the Artemis Health Prenatal Aneuploidy Diagnostic Test
Status: Archived
Advanced Research Associates
mi
from
Corpus Christi, TX
MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy
A Prospective, Multi-center Observational Study With Blinded, Nested Case:Control Analyses to Evaluate the Performance of the Artemis Health Prenatal Aneuploidy Diagnostic Test
Status: Archived
Updated: 1/1/1970
Advanced Research Associates
mi
from
Corpus Christi, TX
MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy
A Prospective, Multi-center Observational Study With Blinded, Nested Case:Control Analyses to Evaluate the Performance of the Artemis Health Prenatal Aneuploidy Diagnostic Test
Status: Archived
Woman's Hospital of Texas
mi
from
Houston, TX
MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy
A Prospective, Multi-center Observational Study With Blinded, Nested Case:Control Analyses to Evaluate the Performance of the Artemis Health Prenatal Aneuploidy Diagnostic Test
Status: Archived
Updated: 1/1/1970
Woman's Hospital of Texas
mi
from
Houston, TX
MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy
A Prospective, Multi-center Observational Study With Blinded, Nested Case:Control Analyses to Evaluate the Performance of the Artemis Health Prenatal Aneuploidy Diagnostic Test
Status: Archived
Eastern Va Medical School
mi
from
Norfolk, VA
MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy
A Prospective, Multi-center Observational Study With Blinded, Nested Case:Control Analyses to Evaluate the Performance of the Artemis Health Prenatal Aneuploidy Diagnostic Test
Status: Archived
Updated: 1/1/1970
Eastern Va Medical School
mi
from
Norfolk, VA
Optical Detection of Intravenous Infiltration
Optical Detection of Intravenous Infiltration
Status: Archived
VCU Medical Center
mi
from
Richmond, VA
Optical Detection of Intravenous Infiltration
Optical Detection of Intravenous Infiltration
Status: Archived
Updated: 1/1/1970
VCU Medical Center
mi
from
Richmond, VA
Task-Based Functional MRI (fMRI) in Patients With Severely Bothersome Tinnitus
Task-Based Functional MRI (fMRI) Exploration of the Cortical Attention Network in Patients With Severely Bothersome Tinnitus
Status: Archived
Washington University
mi
from
St. Louis, MO
Task-Based Functional MRI (fMRI) in Patients With Severely Bothersome Tinnitus
Task-Based Functional MRI (fMRI) Exploration of the Cortical Attention Network in Patients With Severely Bothersome Tinnitus
Status: Archived
Updated: 1/1/1970
Washington University
mi
from
St. Louis, MO
An Interactive Informed Consent and Education Program for Pregnant Women
An Interactive Informed Consent and Education Program for Pregnant Women
Status: Archived
Northwestern University
mi
from
Chicago, IL
An Interactive Informed Consent and Education Program for Pregnant Women
An Interactive Informed Consent and Education Program for Pregnant Women
Status: Archived
Updated: 1/1/1970
Northwestern University
mi
from
Chicago, IL
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
Phoenix Children's Hospital
mi
from
Phoenix, AZ
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
Updated: 1/1/1970
Phoenix Children's Hospital
mi
from
Phoenix, AZ
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
City of Hope Comprehensive Cancer Center
mi
from
Duarte, CA
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
Updated: 1/1/1970
City of Hope Comprehensive Cancer Center
mi
from
Duarte, CA
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
Miller Children's Hospital Long Beach
mi
from
Long Beach, CA
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
Updated: 1/1/1970
Miller Children's Hospital Long Beach
mi
from
Long Beach, CA
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
Updated: 1/1/1970
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
Oakland Children's Hospital
mi
from
Oakland, CA
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
Updated: 1/1/1970
Oakland Children's Hospital
mi
from
Oakland, CA
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
Stanford Clinical Research Center
mi
from
Stanford, CA
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
Updated: 1/1/1970
Stanford Clinical Research Center
mi
from
Stanford, CA
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
University of California at San Francisco (UCSF)
mi
from
San Francisco, CA
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753]
Status: Archived
Updated: 1/1/1970
University of California at San Francisco (UCSF)
mi
from
San Francisco, CA